Avi Polymers Other Announcement
AVI Polymers Ltd updated that its equity shares remain temporarily suspended. The company has applied to BSE for revocation and operations continue normally.
ALFA Filings
Every announcement, straight from the exchange
Announcement type
Time
22 announcements with these filters
AVI Polymers Ltd updated that its equity shares remain temporarily suspended. The company has applied to BSE for revocation and operations continue normally.
AVI Polymers clarified that its trading suspension resulted from a physical verification misunderstanding at its registered office. The company is coordinating with BSE to revoke the suspension.
AVI Polymers issued a postal ballot notice seeking approval for a 1:10 bonus issue and a 10-for-1 stock split. The move aims to rationalize capital.
AVI Polymers approved a 1:10 bonus issue and a 10-for-1 stock split. The board also authorized increasing share capital to ₹105 Crore to accommodate these changes.
AVI Polymers Limited submitted its Annual Secretarial Compliance Report for FY2026. The report details minor procedural deviations and governance disclosures as per SEBI regulations.
AVI Polymers scheduled a board meeting for June 4, 2026. Agenda includes a 1:10 stock split, 10:1 bonus issue, and green tech business diversification.
AVI Polymers appointed Ms. Pushpa Joshi as an Independent Director for five years. This appointment strengthens board independence and ensures regulatory compliance.
AVI Polymers Ltd approved the acquisition of a 90% stake in JVTR Consultants Private Limited at an indicative valuation of ₹500 Crore via share swap. The company is also pivoting into the technology sector, amending its Memorandum of Association to include IT and software development services.
AVI Polymers Ltd launched its 'Ashwini Healthcare AI' platform, securing over 5,620 registered users. The company anticipates an initial cohort of 600-900 paying subscribers, projecting a Year-1 baseline ARR of ₹0.06 Crore to ₹0.09 Crore. Long-term targets include scaling to ₹12 Crore ARR for Series-A valuation metrics.
AVI Polymers Ltd has scheduled a Board Meeting for May 07, 2026, to evaluate a ₹500 Crore fund-raising proposal. The board will also consider expanding its business objects into technology and software services. The trading window is closed from May 04 until 48 hours after the meeting.
AVI Polymers Ltd has officially launched its AI-driven personal healthcare platform, Ashwini.tech (AVI Health AI). Fully funded by a recent ₹89.99 Crore capital infusion, the platform offers real-time wellness analytics and diagnostic assistance. This launch completes the company's dual-engine AI strategy, positioning it at the intersection of AgriTech and HealthTech markets.
AVI Polymers Ltd promoters intend to acquire up to 5% of the company's equity via open market purchases. The move follows strong FY26 results with ₹312.11 Crore revenue and a debt-free balance sheet. The acquisitions will be executed in phases, reflecting management's conviction in the company's strategic pivot into a high-growth technology enterprise.
AVI Polymers reported a significant turnaround in FY26, with revenue reaching ₹312.11 Crore and net profit at ₹20.33 Crore. The company successfully completed a ₹89.99 Crore rights issue and is launching its AI platforms, KrishiBuddy and AVIHealth AI. These developments mark a strategic shift towards technology-enabled growth in agritech and healthtech sectors.
AVI Polymers Ltd has submitted a certificate confirming it is outside the purview of the Large Corporate criteria as of March 31, 2026. This disclosure is in compliance with SEBI's framework for fund raising by issuance of debt securities. The company currently does not meet the specified applicability thresholds.
AVI Polymers Ltd reported revenue from operations of ₹150.3 Cr and net profit of ₹10.2 Cr (+1357.1% YoY) for Q4 FY26.
AVI Polymers Ltd approved its FY26 audited results, reporting a consolidated total income of ₹312.59 Crore. The company achieved breakout growth with a 25x profit surge and concluded an ₹89.99 Crore rights issue. Management also announced the upcoming launch of 'AVI Health AI' and deferred dividends to reinvest in digital expansion.
AVI Polymers Ltd has scheduled a Board Meeting on April 27, 2026, to approve audited FY26 financial results and recommend a dividend up to 50%. The Board will also consider a strategic expansion into the Healthcare Technology sector via its subsidiary, AVI AI Technologies.
AVI Polymers reported Q3 FY26 net sales of ₹132.32 Cr and PAT of ₹7.02 Cr. Strategy shifts from specialty chemicals to an AI-first agritech platform 'KrishiBuddy' via subsidiary AVI Eco Spark.
AVI Polymers Ltd launched 'KrishiBuddy', an AI-driven agritech platform developed by its subsidiary AVI Eco Spark. The company also reported a Q3 FY26 net profit of ₹7.02 Crore. This pivot into high-margin technology solutions signals a significant strategic shift from its traditional polymer manufacturing business.
AVI Polymers Limited's subsidiary, AVI Eco Spark Private Limited, launched its AI-powered 'KrishiBuddy' agritech platform. The platform provides Indian smallholder farmers with satellite-based crop monitoring, financial modeling, and multilingual AI assistance. This marks a strategic pivot toward high-growth technology sectors like AI and IoT in agriculture.
AVI Polymers Limited's subsidiary launched 'KrishiBuddy', an AI-powered agritech platform for Indian smallholder farmers. The application integrates satellite imagery and predictive financial modelling to provide crop health monitoring and profit calculation. This launch marks the company's strategic expansion into high-growth technological sectors like artificial intelligence and IoT ecosystems in Indian agriculture.
Avi Polymers Ltd reported net profit of ₹7 Cr for Q3 FY26.